Search Results for 'svr treatment'

svr treatment published presentations and documents on DocSlides.

Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Edited by
Edited by
by ellena-manuel
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Alcohol Use in Chronic Hepatitis C Infection
Alcohol Use in Chronic Hepatitis C Infection
by cecilia
Lamia Haque. WHAT-IF Session. July 2019. Backgrou...
Update on the HCV Antiviral Pipeline
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Hepatitis C: A New Era In Treatment And Cure
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Current strategies for the management of treatment naïve a
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
ALLY-3 Design Objective SVR
ALLY-3 Design Objective SVR
by mitsue-stanley
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Advances in Hepatitis C Identification and Treatment
Advances in Hepatitis C Identification and Treatment
by giovanna-bartolotta
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...
Treatment with the second-generation HCV protease inhibitor
Treatment with the second-generation HCV protease inhibitor
by conchita-marotz
Results from SILEN-C1 in HCV genotype-1 treatment...
Simeprevir in
Simeprevir in
by cheryl-pisano
Treatment –Experienced Genotype . 1 . ASPIRE Tr...
Real World Data
Real World Data
by kittie-lecroy
REAL-WORLD SAFETY AND EFFECTIVENESS OF OMBITASVIR...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Updates in Treatment of Hepatitis C
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by webraph
Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...
Viral hepatitis Best of ILC 2019
Viral hepatitis Best of ILC 2019
by stella
About these slides. These slides provide highlight...
What’s New in Hepatitis C
What’s New in Hepatitis C
by debby-jeon
Diana L. . Sylvestre. , MD. University of CA, San...
Hepatitis C Drug 		 	   Pipeline
Hepatitis C Drug Pipeline
by cheryl-pisano
HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...
Single arm Open label ≥ 
Single arm Open label ≥ 
by ellena-manuel
18 years. BMI ≥ 18 kg/m. 2. HCV genotype 2, 4, ...
May 3, 2016: Hepatitis  C Kills More Americans than Any Other Infectious
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
by luanne-stotts
Disease. Annual Hepatitis . C-related mortality i...
Resistance to Direct Acting Antiviral Therapy
Resistance to Direct Acting Antiviral Therapy
by tawny-fly
Resistance to HCV DAAs: What is the threat level...
Liver tumours Best of ILC 2018
Liver tumours Best of ILC 2018
by karlyn-bohler
About these slides. These slides provide highligh...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
 Liver tumours Best of ILC 2018
Liver tumours Best of ILC 2018
by min-jolicoeur
About these slides. These slides provide highligh...
Design Sofosbuvir / velpatasvir
Design Sofosbuvir / velpatasvir
by fullyshro
for 12 weeks in liver transplant recipients with g...
The Paradox of Highly Effective
The Paradox of Highly Effective
by Kingslayer
Sofosbuvir. . Combo Therapy . Despite . Slow . He...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Confronting Hepatitis C and HIV Among the Homeless
Confronting Hepatitis C and HIV Among the Homeless
by delilah
Marguerite Beiser, ANP-BC, AAHIVS. Boston Health C...